Experts Outline COVID-19 Trends, Flu Season Predictions
August 31st 2021Doug Long, vice president of industry relations at IQVIA, and Scott Biggs, director of supplier services, discussed their session at the 2021 National Association of Chain Drug Stores (NACDS) Total Store Expo titled "Pharmaceutical Trends, Issues, and Forecasts."
Watch
Study Suggests Benefits For Oral Cannabidiol in Hospitalized Patients With COVID-19
August 31st 2021In an interview with Pharmacy Times®, Guillermo Torre-Amione, MD, PhD, FACC, the chairman of Cardiol Therapeutics, discusses the potential use for CBD in hospitalized patients with COVID-19, as well as its therapeutic benefits in certain patients with cardiovascular disease.
Watch
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP, director of Accreditation and Medication Safety at Cardinal Health and member of US Pharmacopeia’s (USP) Compounding Expert Committee, and Nicole Palmer, the senior manager of USP Volunteer Operations, discuss USP’s volunteer program.
Watch
Caution, Increased Education About Opioid Use for People With Heart Disease Urged by Experts
August 31st 2021The AHA worked with a team of leading health authorities to develop the advisory, which highlights recommendations, algorithms, and guidance for health care professionals and researchers who specialize in heart and brain health.
Read More
Lisdexamfetamine Reduces Symptoms of Cognitive Sluggishness in Adult Patients With ADHD
August 31st 2021It is currently debated whether or not sluggish cognitive tempo—defined as a collection of symptoms that include persistent dreaminess, fatigue, and slow working speed—is part of ADHD or separate from it.
Read More
Updates in Provider Status for Pharmacists
August 30th 2021Pharmacy Times spoke with Dr. Trishia Shaw, the Clinical Assistant Professor of Pharmacy Practice at Chicago State University College of Pharmacy, on her presentation at the NPhA conference titled “Who’s your Provider”—Updates in Provider Status for Pharmacists.
Watch
FDA Approves Brivaracetam for Treatment of Partial-Onset Seizures in Pediatric Patients
August 30th 2021This is the first time that the intravenous (IV) formulation of brivaracetam will be available for pediatric patients and is the only IV formulation approved for partial-onset seizures and this age group in nearly 7 years.
Read More
COVID-19 Boosters, Flu Season, and the Future of the Pandemic
August 27th 2021In an interview with Pharmacy Times®, Sachin Nagrani, MD, medical director at the home visit and telemedicine service Heal, discusses the Biden administration's announcement that booster shots will soon be available for the Pfizer and Moderna vaccines, and what this would mean for patients and practitioners.
Watch